News – Page 888 – Endpoints News

Evenity finally wins EU approval; US-China biologics CDMO raises $60M

6 years ago

KRAS analysis vaults Merck's flagship Keytruda back into the spotlight

6 years ago

AstraZeneca joins Merck, Bristol-Myers in China's checkpoint race as regulators OK first PD-L1

6 years ago

On the heels of promising MCL data, Kite hustles its 2nd CAR-T to the FDA as the next big race in the field draws to ...

6 years ago

Correvio is putting itself up on the auction block after FDA review panel points to another rejection

6 years ago

In a key step for psychedelic research, magic mushroom compound clears first clinical safety hurdle

6 years ago

Alphamab Oncology rounds out HKEX's second biotech IPO year with $230M raise and high local interest

6 years ago

For sale: Long-acting PhIII GLP-1 diabetes drug that’s way behind rivals, now spurned by Sanofi

6 years ago

Parkinson's transplants emerge as stem cell pioneer Jeanne Loring joins R&D race

6 years ago

FDA slaps down Alkermes for misleading Vivitrol ads — don't forget vulnerability to opioid overdose

6 years ago

FDA in-house review spotlights an issue with one of Horizon's endpoints but notes efficacy for lead drug

6 years ago

Seattle Genetics details positive OS and PFS data for tucatinib in breast cancer

6 years ago

Stefan Fraenkel takes over as chief of Inceptua Group; Christi Shaw has a plan to make Yescarta safer

6 years ago

Battered, cash hungry Intec feels the burn of Novartis rejection

6 years ago

What does $6.9B buy these days in oncology R&D? AstraZeneca has a landmark answer

6 years ago

Bristol-Myers shows off a low-profile AML contender it gained from Celgene buyout — and they’re taking it ...

6 years ago

Deserted by Astellas and Merck, little Correvio still can't win over FDA panel concerned with its AFib drug's safety

6 years ago

New trade deal knocks out long-sought biologics protections for drugmakers

6 years ago

With looming superbug crisis, Iterum misses in a key antibiotic trial — and its shares tumble

6 years ago

Little Leo Pharma enters the prize-fight ring with positive PhIII atopic dermatitis data. Now they just have to beat ...

6 years ago

After several high profile startup launches, omnivorous Omega Funds closes $438M fund to pursue more deals

6 years ago

Foreign drug inspections decline as FDA hiring struggles continue

6 years ago

Amgen puts its foot down in shiny new South San Francisco hub as it reorganizes R&D ops

6 years ago

AstraZeneca teams up with Deep Matter for AI drug development; Cancer biotech ImmunOs raises $15M

6 years ago

First page Previous page 885 886 887888889 890 891 Next page Last page